SPY334.12+2.01 0.61%
DIA273.87+1.87 0.69%
IXIC11,103.73+105.33 0.96%

Bio-Rad Laboratories Q2 EPS $1.61 Beats $1.15 Estimate, Sales $536.90M Beat $503.82M Estimate

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $1.61 per share which beat the analyst consensus estimate of $1.15 by 40 percent. This is a 2.55 percent increase over earnings of $1.57 per share from the

Benzinga · -
Bio-Rad Laboratories (NYSE: BIO) reported quarterly earnings of $1.61 per share which beat the analyst consensus estimate of $1.15 by 40 percent. This is a 2.55 percent increase over earnings of $1.57 per share from the same period last year. The company reported quarterly sales of $536.90 million which beat the analyst consensus estimate of $503.82 million by 6.57 percent. This is a 6.24 percent decrease over sales of $572.62 million the same period last year.